Inhibition of miR‑155‑5p attenuates the valvular damage induced by rheumatic heart disease
Ang Chen(ShanghaiTech University), Zhiyu Zeng(Guangxi University), Feng Huang(Guangxi Medical University), Chuanghong Lu(Guangxi Medical University), Jianlin Wen(Guangxi Medical University), Shenglin Xian(Guangxi Medical University), Zefang Lin(Guangxi Medical University), Yunjiao Wu(Guangxi Medical University)
Cited by 54
Related Papers
NLRP3 Inflammasome as a Molecular Marker in Diabetic Cardiomyopathy
|Frontiers in Physiology|2017|217
ASAS/WHO ICF Core Sets for ankylosing spondylitis (AS): how to classify the impact of AS on functioning and health
|Annals of the Rheumatic Diseases|2009|138
Association of the SPTLC3 rs364585 polymorphism and serum lipid profiles in two Chinese ethnic groups
|Lipids in Health and Disease|2017|119
Hypoxia inducible factor-1α drives cancer resistance to cuproptosis
|Cancer Cell|2025|119
Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival
|International Journal of Molecular Medicine|2012|118